Cofinimmo Future Growth
Future criteria checks 3/6
Cofinimmo's revenue is forecast to decline at 0.1% per annum while its annual earnings are expected to grow at 79.4% per year. EPS is expected to grow by 1.8% per annum. Return on equity is forecast to be 6.9% in 3 years.
Key information
79.4%
Earnings growth rate
1.8%
EPS growth rate
Health Care REITs earnings growth | 32.1% |
Revenue growth rate | -0.1% |
Future return on equity | 6.9% |
Analyst coverage | Good |
Last updated | 30 Oct 2024 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 367 | 291 | 237 | N/A | 9 |
12/31/2025 | 358 | 278 | 224 | N/A | 9 |
12/31/2024 | 351 | 106 | 332 | N/A | 9 |
9/30/2024 | 394 | -52 | N/A | N/A | N/A |
6/30/2024 | 392 | -41 | 254 | 255 | N/A |
3/31/2024 | 391 | -55 | N/A | N/A | N/A |
12/31/2023 | 389 | -55 | 227 | 228 | N/A |
9/30/2023 | 385 | 49 | N/A | N/A | N/A |
6/30/2023 | 379 | 185 | 223 | 224 | N/A |
3/31/2023 | 373 | 333 | N/A | N/A | N/A |
12/31/2022 | 368 | 483 | 209 | 210 | N/A |
9/30/2022 | 367 | 565 | N/A | N/A | N/A |
6/30/2022 | 357 | 489 | 205 | 206 | N/A |
3/31/2022 | 351 | 382 | N/A | N/A | N/A |
12/31/2021 | 343 | 260 | 199 | 200 | N/A |
9/30/2021 | 328 | 189 | N/A | N/A | N/A |
6/30/2021 | 312 | 155 | 185 | 186 | N/A |
3/31/2021 | 276 | 122 | N/A | N/A | N/A |
12/31/2020 | 293 | 119 | 178 | 180 | N/A |
9/30/2020 | 296 | 170 | N/A | N/A | N/A |
6/30/2020 | 266 | 193 | 166 | 167 | N/A |
3/31/2020 | 292 | 222 | N/A | N/A | N/A |
12/31/2019 | 285 | 205 | 169 | 169 | N/A |
9/30/2019 | 241 | 134 | N/A | N/A | N/A |
6/30/2019 | 270 | 119 | 182 | 182 | N/A |
3/31/2019 | 259 | 105 | N/A | N/A | N/A |
12/31/2018 | 263 | 146 | 160 | 161 | N/A |
9/30/2018 | 260 | 186 | N/A | N/A | N/A |
6/30/2018 | 258 | 170 | N/A | 140 | N/A |
3/31/2018 | 264 | 166 | N/A | N/A | N/A |
12/31/2017 | 263 | 137 | N/A | 157 | N/A |
9/30/2017 | 267 | 121 | N/A | N/A | N/A |
6/30/2017 | 267 | 128 | N/A | 168 | N/A |
3/31/2017 | 275 | 134 | N/A | N/A | N/A |
12/31/2016 | 257 | 97 | N/A | 144 | N/A |
9/30/2016 | 253 | 100 | N/A | N/A | N/A |
6/30/2016 | 255 | 82 | N/A | 148 | N/A |
3/31/2016 | 249 | 110 | N/A | N/A | N/A |
12/31/2015 | 255 | 104 | N/A | 170 | N/A |
9/30/2015 | 260 | 76 | N/A | N/A | N/A |
6/30/2015 | 262 | 66 | N/A | 158 | N/A |
3/31/2015 | 264 | -59 | N/A | N/A | N/A |
12/31/2014 | 259 | -53 | N/A | 149 | N/A |
9/30/2014 | 270 | -51 | N/A | N/A | N/A |
6/30/2014 | 274 | -39 | N/A | 150 | N/A |
3/31/2014 | 276 | 37 | N/A | N/A | N/A |
12/31/2013 | 273 | 59 | N/A | 153 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 0J3X is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.1%).
Earnings vs Market: 0J3X is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: 0J3X is expected to become profitable in the next 3 years.
Revenue vs Market: 0J3X's revenue is expected to decline over the next 3 years (-0.1% per year).
High Growth Revenue: 0J3X's revenue is forecast to decline over the next 3 years (-0.1% per year).
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 0J3X's Return on Equity is forecast to be low in 3 years time (6.9%).